SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-296205
Filing Date
2021-10-12
Accepted
2021-10-12 06:10:02
Documents
12
Period of Report
2021-10-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d239269d8k.htm   iXBRL 8-K 28616
  Complete submission text file 0001193125-21-296205.txt   156517

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rphm-20211011.xsd EX-101.SCH 2890
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rphm-20211011_lab.xml EX-101.LAB 18889
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rphm-20211011_pre.xml EX-101.PRE 11859
5 EXTRACTED XBRL INSTANCE DOCUMENT d239269d8k_htm.xml XML 3480
Mailing Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612
Business Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612 (858) 283-0280
Reneo Pharmaceuticals, Inc. (Filer) CIK: 0001637715 (see all company filings)

IRS No.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40315 | Film No.: 211316661
SIC: 2834 Pharmaceutical Preparations